These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 25400807)
1. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma. Wu W; Li W; Zhou Y; Zhang C Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807 [TBL] [Abstract][Full Text] [Related]
2. Expression of Beclin1 in osteosarcoma and the effects of down-regulation of autophagy on the chemotherapeutic sensitivity. Zhang Z; Shao Z; Xiong L; Che B; Deng C; Xu W J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):737-40. PubMed ID: 20037818 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186 [TBL] [Abstract][Full Text] [Related]
4. Effect of autophagy-related beclin1 on sensitivity of cisplatin-resistant ovarian cancer cells to chemotherapeutic agents. Sun Y; Liu JH; Jin L; Sui YX; Han LL; Huang Y Asian Pac J Cancer Prev; 2015; 16(7):2785-91. PubMed ID: 25854363 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells. Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487 [TBL] [Abstract][Full Text] [Related]
6. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells. Gao S; Wang K; Wang X Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125 [TBL] [Abstract][Full Text] [Related]
7. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma. He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p. Cheng FH; Zhao ZS; Liu WD Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112 [TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line. Tao H; Chen F; Liu H; Hu Y; Wang Y; Li H Mol Med Rep; 2017 Aug; 16(2):1701-1706. PubMed ID: 28656199 [TBL] [Abstract][Full Text] [Related]
10. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling. Zhou Q; Hu T; Xu Y J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159 [TBL] [Abstract][Full Text] [Related]
11. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma]. Tian J; Hu X; Qu Q Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585 [TBL] [Abstract][Full Text] [Related]
12. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. Yu Z; Li N; Jiang K; Zhang N; Yao LL Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells. Zhang W; Li Q; Song C; Lao L Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts. Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058 [TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts. Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781 [TBL] [Abstract][Full Text] [Related]
17. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1. Shen C; Wang W; Tao L; Liu B; Yang Z; Tao H Int J Mol Med; 2013 Aug; 32(2):448-56. PubMed ID: 23722646 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells. Zhou X; Natino D; Zhai X; Gao Z; He X Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068 [TBL] [Abstract][Full Text] [Related]
20. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]